Skip to main content
Clinical Trials/NCT05836285
NCT05836285
Recruiting
Not Applicable

The ARRC III Trial of Advanced Recovery Room Care (ARRC).

University of Adelaide1 site in 1 country3,000 target enrollmentApril 18, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post-Surgical Complication
Sponsor
University of Adelaide
Enrollment
3000
Locations
1
Primary Endpoint
Days at Home after surgery
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

A postoperative high-acuity model of care (ARRC) has been shown, in a prospective cohort study of approximately 850 patients, to produce a marked improvement in patient and hospital outcomes, and hospital costs, in medium risk patients (Ludbrook G et al., JAMA Surgery 2023).

The goal of this observational study is to examine the outcomes after non-cardiac surgery of a larger group of medium risk patients receiving different forms of care -ARRC and usual ward care. The main questions it aims to answer are:

what are the outcomes for patients and hospital after the different forms of care, who receives benefit from high acuity care, what underlies the improved outcomes seen with high acuity care.

Detailed Description

Demand for essential surgery is growing, yet we face an increasingly complex casemix and budget challenges. New paradigms to deliver high value care are essential. Advanced Recovery Room Care (ARRC) is a model of care which, at RAH, has been shown to provide substantial improvements in patient outcomes, hospital utilisation, and costs of care. Specifically, it showed when compared to usual ward care: improved Days at Home after Surgery (primary outcome), decreased in-hospital complications, and decreased mortality at 1, 3 and 12 months. This model was cost-effective compared to usual ward care: ICER of approximately -$250 per DAH It is essential to collect high quality data on this model relevant to consumers and hospitals, in order to: * provide a robust mechanism to ensure outcomes are maintained, and ideally improved, within our institution * provide a mechanism to potentially allow benchmarking in the future, across institutions * better identify which surgical subgroups receive benefit from ARRC * provide a resource to generate and test hypotheses as to how these benefits are achieved. To that end, the ARRC II study database is to be refined to function in essence as an ongoing registry. This will be initially piloted at RAH, the subject of this study.

Registry
clinicaltrials.gov
Start Date
April 18, 2023
End Date
December 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Guy Ludbrook

Professor of Anaesthesia

University of Adelaide

Eligibility Criteria

Inclusion Criteria

  • Scheduled for elective or unplanned surgery
  • Scheduled to stay in hospital at least one night after surgery
  • 30-day mortality of 0.5% to 8% by the US National Safety and Quality Improvement Program risk score (NSQIP)

Exclusion Criteria

  • Undergoing cardiac surgery
  • Scheduled for postoperative Intensive Care Unit management

Outcomes

Primary Outcomes

Days at Home after surgery

Time Frame: 90 days after surgery

number of days spent at usual place of residence within 90 days after surgery

Secondary Outcomes

  • mortality(12 months after surgery)
  • in-hospital complications(out to 10 days after surgery)
  • cost-effectiveness(90 days after surgery)

Study Sites (1)

Loading locations...

Similar Trials